VaramirStart free · no cardSign in
AMGN as of Oct 30 · 20:18 ET
AMGNNasdaqBiological Products, (No Diagnostic Substances)

Amgen Inc · Brief

Next report

3 days

Nov 3 · after closeconfirmedQ3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
6 of 8≥ implied
avg implied
±4.0%
avg realized
±4.9%
Oct 30 '24±4.2%▲+1.46%×0.34
Feb 4 '25±3.7%▲+6.50%×1.78
May 1 '25±4.4%▼−0.90%×0.21
Aug 5 '25±4.0%▼−5.14%×1.30
Q3 FY25±3.7%▲+7.81%×2.13
Feb 3 '26±3.7%▲+8.15%×2.18
Q1 FY26±3.9%▼−4.75%×1.22
Q2 FY26±4.1%▲+4.57%×1.11
quarterimplied−10%0+10%realized×
Q2 FY26±4.1%▲+4.57%×1.11
Q1 FY26±3.9%▼−4.75%×1.22
Feb '26±3.7%▲+8.15%×2.18
Q3 FY25±3.7%▲+7.81%×2.13
Aug '25±4.0%▼−5.14%×1.30
May '25±4.4%▼−0.90%×0.21
2 older reports
Feb '25±3.7%▲+6.50%×1.78
Oct '24±4.2%▲+1.46%×0.34
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 3 report · confirmed

Bull2 of 4

3,165managers reporting a position in the latest quarterly filings13F · Jun 30 '26
+3.66%change in shares held by the ten largest reporting managers over the latest quarter13F · Jun 30 '26

Bear2 of 3

10 of 23of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26
64managers whose positions together make up four fifths of the reported value13F · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

AMGN report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 28report dateEarnings date confirmed: Nov 3, after close.Source
Oct 27N-PORTSCHD: AMGN weight up to 4.70%.Source
Oct 20impliedImplied move: ±5.4% into Nov 3 earnings (Oct 20 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.